Miller Anestesia

207. Kramer HJ: Impaired renal function in obstructive

jaundice: Roles of the thromboxane and endothelin

systems. Nephron 77:1-12, 1997.

208. Inan M, Sayek I, Tel BC, Sahin-Erdemli I: Role of

endotoxin and nitric oxide in the pathogenesis of

renal failure in obstructive jaundice. Br J Surg

84:943-947, 1997.

209. Wahbah AM, el-Hefny MO, Wafa EM, et al: Perio-

perative renal protection in patients with obstruc-

tive

jaundice

using

drug

combinations.

Hepatogastroenterology 47:1691-1698, 2000.

210. Sanyal AJ, Stravitz RT: Acute liver failure.

ZakimD,

Boyer D (eds): Hepatology: A Textbook of Liver

Disease. Philadelphia, WB Saunders, 2003, pp 445-

496.

211. McCammon RL, Stoelting RK, Madura JA: Effects

of butorphanol, nalbuphine, and fentanyl on intra-

biliary tract dynamics. Anesth Analg 63:139-142,

1984.

212. Radnay PA, Duncalf D, Novakovic M, Lesser ML:

Common bile duct pressure changes after fentanyl,

morphine, meperidine, butorphanol, and naloxone.

Anesth Analg 63:441-444, 1984.

213. Jones RM, Detmer M, Hill AB, et al: Incidence of

choledochoduodenal sphincter spasm during fen-

tanyl-supplemented anesthesia. Anesth Analg

60:638-640, 1981.

214. Greaves R, Miller J, O’Donnell L, et al: Effect of the

nitric oxide donor, glyceryl trinitrate, on human

gallbladder motility. Gut 42:410-413, 1998.

215. Madacsy L, Velosy B, Szepes A, et al: Effect of nitric

oxide on gallbladder motility in patients with acal-

culous biliary pain: A cholescintigraphic study. Dig

Dis Sci 47:1975-1981, 2002.

216. Fragen RJ, Fatima V, Spies S, Erwin WD: The effect

of remifentanil on biliary tract drainage into the

duodenum. Anesth Analg 89:1561, 1999.

217. Riordan SM, Williams R: Treatment of hepatic

encephalopathy. N Engl J Med 337:473-479, 1997.

218. Blei A, Larsen FS: Pathophysiology of cerebral

edema in fulminant hepatic failure. J Hepatol

31:771-776, 1999.

219. Ochs A, Rossle M, Haag K, et al: The transjugular

intrahepatic portosystemic stent-shunt procedure

for refractory ascites. N Engl J Med 332:1192-1197,

1995.

220. Pomier-Layrargues G, Giguere JF, Lavoie J, et al:

Flumazenil in cirrhotic patients in hepatic coma: A

randomized double-blind placebo-controlled cros-

sover trial. Hepatology 19:32-37, 1994.

221. Clemmesen JO, Gerbes AL, Gulberg V, et al: Hepatic

blood flow and splanchnic oxygen consumption in

patients with liver failure: Effect of high-volume

plasmapheresis. Hepatology 29:347-355, 1999.

222. Menon KVN, Kamath PS: Managing the complica-

tions of cirrhosis. Mayo Clin Proc 75:501-509,

2000.

223. Lamberts SWJ, van der Lely AJ, de Herder WW,

Hofland LJ: Octreotide. N Engl J Med 334:246-254,

1996.

224. Roberts LR, Kamath PS: Ascites and hepatorenal

syndrome: Pathophysiology and management.

Mayo Clin Proc 71:874-881, 1996.

225. Epstein M: Hepatorenal syndrome: Emerging pers-

pectives of pathophysiology and therapy. J Am Soc

Nephrol 4:1735-1753, 1994.

226. Lange PA, Stoller JK: The hepatopulmonary syn-

drome. Ann Intern Med 122:521-529, 1995.

227. Quiroga J, Sangro B, Nunez M: Transjugular intra-

hepatic portosystemic shunt in the treatment of

refractory ascites: Effect on clinical, renal, humoral

and hemodynamic parameters. Hepatology 21:986-

994, 1995.

228. Clavien P-A, Petrowsky H, DeOliveira ML, Graf R:

Strategies for safer liver surgery and partial liver

transplantation. N Engl J Med 356:1545-1559,

2007.

229. Fong Y, Cohen J, Fortner J: Liver resection for colo-

rectal metastases. J Clin Oncol 15:938-946, 1997.

230. Littlewood K: Anesthetic considerations for hepatic

cryotherapy. Semin Surg Oncol 14:116-121, 1998.

Anestesia y el sistema hepatobiliar

1919

Sección IV

Anestesia por subespecialidades en el adulto